Business Wire

Six Premier Craft Beverage Equipment Suppliers Merge in $100 Million Deal to Launch First-Ever One-Stop-Shop for All Craft Beverage Needs

20.4.2023 14:30:00 EEST | Business Wire | Press release

Share

Lotus Beverage Alliance, a collective of experienced craft beverage equipment manufacturing companies, today announced that it has officially launched as a company. Six leading American craft beverage equipment suppliers have merged in a $100 million deal to create Lotus Beverage Alliance. The combined capabilities of Lotus Beverage Alliance will enable beverage manufacturers of all sizes to access the most comprehensive array of products spanning every step of production for craft beer, wine, hard cider, spirits, cold brew coffee, ready-to-drink cocktails, kombucha, CBD/THC-infused drinks, and sake beverages.

The six merged companies, Alpha Brewing Operations, GW Kent, Twin Monkeys, Stout Tanks and Kettles, Brewmation, and Automated Extractions, are leaders in craft beverage equipment manufacturing and offer essential infrastructure and technology for diversifying the craft beverage industry. The five founders of the six companies will remain in senior leadership positions at Lotus: Matt Rennerfeldt, John Watt, Kevin Weaver, Josh Van Riper, and Randy Reichwage. John Ansbro, an industry veteran with more than 30 years of experience in equipment manufacturing, has been named Chief Executive Officer for Lotus. Ansbro has held senior executive positions at Alfa Laval, Johnson Controls, and the GEA Group.

“Lotus has everything craft beverage creators need to produce the amazing artisanal products they love, for people who love them,” said John Ansbro, CEO of Lotus Beverage Alliance. “Our team’s proven industry experience includes a deep bench of experts helping to optimize the production of handcrafted beverages for consumers to enjoy.”

Lotus Beverage Alliance brings these leading equipment makers under one roof to become the only end-to-end provider dedicated to crafting possibilities for beverage makers, from nationally-distributed beverage purveyors to the everyday craft enthusiast. Lotus Beverage Alliance produces 1,500+ top-shelf products, including turn-key brewhouse production equipment, 304 stainless steel conical fermenters, brew kettles, IBC totes, multi-capacity tanks, mash tuns, brite tanks, canning systems, automation and control systems, packaging, thermal processes and sanitation equipment, raw ingredient supply, parts, and more.

In another industry first, Lotus introduced a proprietary financing program that offers customers affordable financing options, removing cost barriers for startups and smaller beverage producers. Credit approvals typically take less than 24 hours to provide clients with maximum flexibility.

“What a bold vision to pull together such well-respected leaders of each of their respective craft beverage supplier channel segments. The result of this merger for craft beverage makers is sure to be exponential growth and continued beverage innovation,” said Banjo Bandolas, Director of Advertising and Sales at ProBrewer.com. “Lotus appears to be a first-mover by creating a one-stop-shop for craft brewers and companies moving into ‘beyond beer’ products. I look forward to seeing where it evolves.”

Beverage makers who select Lotus Beverage Alliance as their trusted equipment partner can expect:

  • Responsive and expert customer service
  • A one-stop-shop supply chain for all production needs
  • Ready-to-ship production parts and equipment
  • High-performance equipment with extended life cycles
  • Seamless equipment integration with several third-party brands
  • Opportunities for reduced operating costs and downtime through automation
  • Greater uptimes and efficiencies in production processes
  • Post-purchase technical and operations support
  • Proprietary purchase financing program with typical approval in 24 hours

Lotus Beverage Alliance offers extensive support for startups and scale-ups, including:

  • Brewing and Distilling
  • Quick Ship Equipment and Parts
  • Packaging
  • Automation and Controls
  • Extraction Processing
  • Beverage Production Support

Following the six-way merger, the Lotus Beverage Alliance ownership structure includes the founders from all six businesses. Additionally, Lotus has implemented an employee ownership program, at no cost to the employees. Employee ownership has been extended to every single employee throughout the organization. Research has shown that broad-based employee ownership programs improve worker retention, reduce income disparity, and result in higher margins, as well as improved growth and operating efficiencies across various aspects of a business. Lotus collaborated with Ownership Works (https://ownershipworks.org/) in this employee ownership program’s creation. The Lotus merger was facilitated by Ronin Equity Partners, a New York-based investment firm with a long-term growth focus. Ronin is also an investor in Lotus.

Lotus Beverage Alliance will be an exhibitor at the Specialty Coffee Expo in Portland, Oregon, Apr. 21–23, at Booth #456; and at the Craft Brewers Conference in Nashville, Tennessee, May 7-10, 2023 at Booths #500 and #945.

About L otus Beverage Alliance:

Lotus Beverage Alliance is a collective group of experienced companies with extensive knowledge and professional insight into the craft beverage industry. The organization was formed to bring excitement and resources to craft brewing companies by providing an advanced and comprehensive product line, knowledgeable technical guidance, immediate equipment and parts availability, and an excellent customer service team. To learn more about Lotus Beverage Alliance, please visit lotusbevalliance.com. Crafting possibilities.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For Media Inquiries, Please Contact:

Craft beer media:
Jesse P. Cutler, JP Cutler Media, 415.318.9663, jesse@jpcutlermedia.com

Wine/spirits/specialty beverage media:
Michelle Barry, Chameleon Collective
603.809.2748
LotusBeverage@chameleon.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 12:18:00 EEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 11:11:00 EEST | Press release

Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye